AU2021301264A1 - Compounds having antibacterial activity - Google Patents
Compounds having antibacterial activity Download PDFInfo
- Publication number
- AU2021301264A1 AU2021301264A1 AU2021301264A AU2021301264A AU2021301264A1 AU 2021301264 A1 AU2021301264 A1 AU 2021301264A1 AU 2021301264 A AU2021301264 A AU 2021301264A AU 2021301264 A AU2021301264 A AU 2021301264A AU 2021301264 A1 AU2021301264 A1 AU 2021301264A1
- Authority
- AU
- Australia
- Prior art keywords
- group
- heteroaryl
- aryl
- alkyl
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063047612P | 2020-07-02 | 2020-07-02 | |
| US63/047,612 | 2020-07-02 | ||
| PCT/US2021/040143 WO2022006432A1 (en) | 2020-07-02 | 2021-07-01 | Compounds having antibacterial activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2021301264A1 true AU2021301264A1 (en) | 2023-02-02 |
Family
ID=79314944
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021301264A Pending AU2021301264A1 (en) | 2020-07-02 | 2021-07-01 | Compounds having antibacterial activity |
| AU2021299504A Pending AU2021299504A1 (en) | 2020-07-02 | 2021-07-01 | Compounds having anticancer activity |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021299504A Pending AU2021299504A1 (en) | 2020-07-02 | 2021-07-01 | Compounds having anticancer activity |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20230295164A1 (enExample) |
| EP (2) | EP4175953A4 (enExample) |
| JP (2) | JP2023532128A (enExample) |
| CN (2) | CN115867354B (enExample) |
| AU (2) | AU2021301264A1 (enExample) |
| CA (2) | CA3183770A1 (enExample) |
| WO (2) | WO2022006447A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024531898A (ja) * | 2021-08-17 | 2024-09-03 | サウスウエスト リサーチ インスティテュート | コロナウイルスに対する阻害剤 |
| US20260138981A1 (en) * | 2022-10-07 | 2026-05-21 | The Trustees Of Princeton University | Dihydrofolate reductase inhibitors for anti-biotic resistant infections |
| CN118047780A (zh) * | 2022-11-09 | 2024-05-17 | 中国医学科学院药物研究所 | 一类喹唑啉杂环化合物及其抗感染和抗肿瘤的应用 |
| CN119661535B (zh) * | 2023-09-21 | 2026-03-20 | 中国医学科学院药物研究所 | 7H-吡咯并[3,2-f]喹唑啉衍生物及其抗感染应用 |
| WO2025195460A1 (zh) * | 2024-03-22 | 2025-09-25 | 深圳湾实验室坪山生物医药研发转化中心 | 稠环衍生物 |
| CN121013722A (zh) * | 2024-03-22 | 2025-11-25 | 深圳湾实验室坪山生物医药研发转化中心 | 结核病的预防与治疗 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE45427B1 (en) * | 1976-07-09 | 1982-08-25 | American Home Prod | Pyrrold 3,2if quinazoline-1,3-diamine and related compounds |
| US4118561A (en) * | 1977-04-06 | 1978-10-03 | American Home Products Corporation | 7-(Substituted)-7H-pyrrolo[3,2-f]quinazoline-1,3-diamines |
| JP2005500253A (ja) * | 2001-02-23 | 2005-01-06 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | トロンビン受容体アンタゴニストとしてのアミノメチルピロロキナゾリン化合物 |
| US7253177B2 (en) * | 2004-10-22 | 2007-08-07 | United States Of America As Represented By The Secretary Of The Army | Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives |
| US9920058B2 (en) * | 2013-05-06 | 2018-03-20 | Georgia Tech Research Corporation | Molecules with potent DHFR binding affinity and antibacterial activity |
| WO2014205272A1 (en) * | 2013-06-20 | 2014-12-24 | Oregon Health & Science University | Pyrroloquinazoline compounds |
| EP3143036B1 (en) * | 2014-05-11 | 2023-08-02 | Tel Hashomer Medical Research Infrastructure and Services Ltd. | Par-1 based therapeutic conjugates and uses thereof |
| US11077109B2 (en) * | 2017-08-01 | 2021-08-03 | The Trustees Of Princeton University | Compounds having antibacterial activity and methods of use |
| US20210161900A1 (en) * | 2018-04-30 | 2021-06-03 | Duke University | Compositions and methods for the treatment of senescent tumor cells |
| WO2021035045A1 (en) * | 2019-08-20 | 2021-02-25 | City Of Hope | Mettl16 inhibitors and uses thereof |
-
2021
- 2021-07-01 CN CN202180047260.2A patent/CN115867354B/zh active Active
- 2021-07-01 JP JP2022581398A patent/JP2023532128A/ja active Pending
- 2021-07-01 CA CA3183770A patent/CA3183770A1/en active Pending
- 2021-07-01 WO PCT/US2021/040171 patent/WO2022006447A1/en not_active Ceased
- 2021-07-01 EP EP21832744.3A patent/EP4175953A4/en active Pending
- 2021-07-01 JP JP2023524493A patent/JP2023535527A/ja active Pending
- 2021-07-01 US US18/014,032 patent/US20230295164A1/en active Pending
- 2021-07-01 WO PCT/US2021/040143 patent/WO2022006432A1/en not_active Ceased
- 2021-07-01 CA CA3183776A patent/CA3183776A1/en active Pending
- 2021-07-01 US US18/013,302 patent/US20230242540A1/en active Pending
- 2021-07-01 EP EP21832527.2A patent/EP4175958A4/en active Pending
- 2021-07-01 CN CN202180047426.0A patent/CN116234808B/zh active Active
- 2021-07-01 AU AU2021301264A patent/AU2021301264A1/en active Pending
- 2021-07-01 AU AU2021299504A patent/AU2021299504A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023532128A (ja) | 2023-07-26 |
| AU2021299504A1 (en) | 2023-02-02 |
| US20230295164A1 (en) | 2023-09-21 |
| EP4175953A4 (en) | 2024-08-14 |
| US20230242540A1 (en) | 2023-08-03 |
| CA3183770A1 (en) | 2022-01-06 |
| CA3183776A1 (en) | 2022-01-06 |
| WO2022006432A1 (en) | 2022-01-06 |
| CN115867354B (zh) | 2025-08-26 |
| WO2022006447A1 (en) | 2022-01-06 |
| JP2023535527A (ja) | 2023-08-17 |
| CN116234808B (zh) | 2025-11-14 |
| CN115867354A (zh) | 2023-03-28 |
| CN116234808A (zh) | 2023-06-06 |
| EP4175953A1 (en) | 2023-05-10 |
| EP4175958A4 (en) | 2024-07-17 |
| EP4175958A1 (en) | 2023-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022006432A1 (en) | Compounds having antibacterial activity | |
| CN115433183B (zh) | Kras抑制剂及其用途 | |
| JP2722280B2 (ja) | 二環式アンサマイシン及び抗腫瘍剤としてのそれらの使用 | |
| CN100436456C (zh) | 具有广谱抗菌作用的含有咪唑并[4,5-b]吡啶甲基的头孢烯化合物 | |
| GB2533136A (en) | Compounds | |
| WO2020163479A1 (en) | Antibiotic ammonium compounds and methods for the treatment of bacterial infections | |
| Yoshizawa et al. | S-3578, a new broad spectrum parenteral cephalosporin exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa synthesis and structure-activity relationships | |
| DE69811367T2 (de) | Cis-substituierte fluoromethylpyrrolidin-derivate | |
| RU2152948C1 (ru) | Диклавулановая соль диаминового эфира и способ ее приготовления | |
| CN108129527B (zh) | 依替米星衍生物及其制备方法、其药物组合物和应用 | |
| RU2757741C1 (ru) | Производное ципрофлоксацина, обладающее антибактериальной активностью в отношении антибиотикоустойчивых штаммов микроорганизмов | |
| US4544501A (en) | Bis(2,2-dimethyl-1-aziridinyl)phosphinic amides for use in the treatment of tumors | |
| KR100529815B1 (ko) | 피리도벤즈옥사진 유도체 및 이를 포함하는 항균제 | |
| CA2328903C (en) | Compounds capable of cleaving double-stranded dna and method of utilization of the same | |
| CN114097804A (zh) | 一种二氨基嘧啶类化合物在防治农业病原菌中的用途 | |
| JPH0114238B2 (enExample) | ||
| CA1247094A (en) | 7-deazapurine derivatives and their production | |
| KR102765205B1 (ko) | 항독력 활성을 가지는 철 킬레이트 화합물 및 이의 용도 | |
| DE10216719A1 (de) | N-(3-Rifamycinyl)carbamate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung und Verhütung von Tuberkulose | |
| Tsuzuki et al. | Elucidating antibacterial activity of heteroleptic triarylbismuthanes and synthesis of amide derivatives through activated ester intermediate | |
| RU2281286C1 (ru) | 11,11-ДИМЕТИЛ-1-ОКСО-1,2,10,11-ТЕТРАГИДРОБЕНЗО [h]ПИРРОЛО[2,1-a]ИЗОХИНОЛИН-2-СПИРО-2-(1-АРИЛ-3-АРОИЛ-4-ГИДРОКСИ-5-ОКСО-2,5-ДИГИДРОПИРРОЛЫ), ПРОЯВЛЯЮЩИЕ АНТИМИКРОБНУЮ АКТИВНОСТЬ ОТНОСИТЕЛЬНО ГРАМПОЛОЖИТЕЛЬНОЙ МИКРОФЛОРЫ | |
| US12616670B2 (en) | N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections | |
| US3894061A (en) | Anilino derivatives of chelocardin | |
| RU2017744C1 (ru) | Способ получения соединений цефема или их кислотно-аддитивных солей | |
| KR100226273B1 (ko) | 신규 세팔로스포린계 수용성 유도체 및 그의 제조방법 |